Private Healthcare Fund III Lp Cormorant serves as Executive at Ambrx Biopharma Inc., where they oversee executive responsibilities. Since joining the company, Private Healthcare Fund III Lp Cormorant has executed 14 insider transactions totaling $36.7M, demonstrating a bullish approach to their equity position. Their most recent transaction on Apr 1, 2024 involved selling 100 shares valued at $305.
Private Healthcare Fund III Lp Cormorant currently holds 3,294,773 shares of Ambrx Biopharma Inc. (AMAM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Private Healthcare Fund III Lp Cormorant has been a net buyer of AMAM stock. They have purchased $35.5M and sold $1.2M worth of shares.
Private Healthcare Fund III Lp Cormorant's most recent insider trade was on Apr 1, 2024, when they sold 100 shares at $3.05 per share.
Get notified when new Form 4 filings are submitted
| $3.03 |
| Discretionary |
| Apr 1, 2024 | IMRX | $307 | Sale | 100 | $3.07 | Discretionary |
| Apr 1, 2024 | IMRX | $921 | Sale | 300 | $3.07 | Discretionary |
| Apr 1, 2024 | IMRX | $1.2M | Sale | 398,600 | $2.90 | Discretionary |
| Apr 1, 2024 | IMRX | $30 | Sale | 10 | $3.01 | Discretionary |
| Apr 1, 2024 | IMRX | $30 | Sale | 10 | $2.98 | Discretionary |
| Apr 1, 2024 | IMRX | $832 | Sale | 280 | $2.97 | Discretionary |
| Apr 17, 2023 | AMAM | $6.0M | Purchase | 562,121 | $10.67 | Discretionary |
| Apr 14, 2023 | AMAM | $8.4M | Purchase | 841,967 | $9.96 | Discretionary |
| Apr 13, 2023 | AMAM | $10.9M | Purchase | 1,193,808 | $9.16 | Discretionary |
| Mar 16, 2023 | AMAM | $5.1M | Purchase | 500,000 | $10.15 | Discretionary |
| Mar 15, 2023 | AMAM | $2.6M | Purchase | 250,000 | $10.60 | Discretionary |
| Mar 14, 2023 | AMAM | $2.5M | Purchase | 250,000 | $9.95 | Discretionary |